Here I use Interpublic Group as a case study, scrutinizing it under elements of an active portfolio management framework. The business produces modestly attractive economics, but is in an earnings ...

Shares of Bristol Myers Squibb declined after the company announced that the late-stage ODYSSEY-HCM study evaluating cardiovascular drug Camzyos (mavacamten) failed. The phase III study was evaluating ...

Recent survey data suggests that investor apprehension regarding a potential stock market crash could actually serve as a boost for stocks. What Happened: The survey revealed that more than half of ...

NeuroPace, Inc. (NASDAQ:NPCE) released preliminary primary endpoint one-year results of the two-year NAUTILUS study evaluating safety and effectiveness of the RNS System for drug-resistant idiopathic ...

A new academic study said people are diverting stock investments into legal gambling. The researchers founded that household investments are reduced by roughly $2 for ever dollar wagered. This has had ...